Posts Tagged ‘advocacy’

By AAHP Board of Directors It’s been nearly a year since the U.S. Food and Drug Administration (FDA) published a draft guidance document that would revoke clearly detailed parameters for manufacturing and distributing homeopathic products. The agency proposed a vague, risk-based approach that could hinder, rather than help us produce readm more…

By AAHP Board of Directors It’s been nearly a year since the U.S. Food and Drug Administration (FDA) published a draft guidance document that would revoke clearly detailed parameters for manufacturing and distributing homeopathic products. The agency proposed a vague, risk-based approach that could hinder, rather than help us produce readm more…